---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-23-000005"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2023-02-22T23:59:59+00:00"
generated_at: "2026-06-19T06:01:15.055896+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Merit Medical Q4 revenue $293.4M (+5.4% YoY); GAAP EPS $0.58 vs $0.36; issues FY2023 guidance

## Summary
- Q4 revenue $293.4M, up 5.4% YoY; constant currency organic revenue up 8.2%.
- GAAP operating margin 10.4% (vs 7.9% Q4 2021); non-GAAP operating margin 17.8% (vs 17.4%).
- GAAP EPS $0.58 (vs $0.36); non-GAAP EPS $0.79 (vs $0.71).
- Issues fiscal year 2023 guidance; specific numbers not provided in excerpt.

## SEC filing metadata
- accession: 0000856982-23-000005
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2023-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698223000005/0000856982-23-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698223000005/mmsi-20230222x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-23-000005
- JSON: https://secwatch.observer/filing/0000856982-23-000005.json
- Plain text: https://secwatch.observer/filing/0000856982-23-000005.txt

## Key facts
- Earnings Releases
  MERIT MEDICAL SYSTEMS INC updated its fiscal year 2023 guidance (initiated).
  - Period: fiscal year 2023
  - Guidance: initiated
  - Result: guidance update
  source text: MERIT MEDICAL REPORTS RESULTS FOR FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2022 ISSUES FISCAL YEAR 2023 GUIDANCE
  evidence_url: https://www.sec.gov/Archives/edgar/data/856982/000085698223000005/0000856982-23-000005-index.htm
- Earnings Releases
  MERIT MEDICAL SYSTEMS INC reported Q4 2022 results: revenue $293.4 million, EPS GAAP EPS $0.58.
  - Period: Q4 2022
  - Revenue: $293.4 million
  - EPS: GAAP EPS $0.58
  - Result: reported results
  source text: ● Q4 2022 reported revenue of $293.4 million, up 5.4% compared to Q4 2021 ● Q4 2022 constant currency revenue, organic* up 8.2% compared to Q4 2021 ● Q4 2022 GAAP operating margin of 10.4%, compared to 7.9% in Q4 2021 ● Q4 2022 non-GAAP operating margin* of 17.8%, compared to 17.4% in Q4 2021 ● Q4 2022 GAAP EPS $0.58, compared to $0.36 in Q4 2021 ● Q4 2022 non-GAAP EPS* of $0.79, compared to $0.71 in Q4 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/856982/000085698223000005/0000856982-23-000005-index.htm
- Earnings Releases
  MERIT MEDICAL SYSTEMS INC reported financial results for the year ended December 31, 2022.
  - Period: the year ended December 31, 2022
  - Result: reported results
  source text: On February 22, 2023, Merit Medical Systems, Inc. (the “Company”) issued a press release announcing its operating and financial results for the quarter and year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/856982/000085698223000005/0000856982-23-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.